Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Seminars in Oncology|October 24, 2018
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapyHammad Shafqat, Theodore Gourdin, Amy SionCancer Chemotherapy and Pharmacology|September 22, 2023
A phase I study of the ceramide nanoliposome in patients with advanced solid tumorsAaron Ciner, Theodore Gourdin, Jeff Davidson, et al.The Oncologist|April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial CarcinomaTomi Jun, Noah M Hahn, Guru Sonpavde, et al.The Oncologist|June 23, 2025
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinomaKathryn E Beckermann, Neil J Shah, Matthew T Campbell, et al.Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.Pageof 2